Medicines as a Service A New Commercial Model for Big Pharma in the Postblockbuster World
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
RAND Corporation
2012
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_115009 | ||
| 005 | 20231005 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231005s2012 xx |||||o ||| 0|eng d | ||
| 020 | |a OP381HLTH | ||
| 020 | |a 9780833076465 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.7249/OP381HLTH |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Mattke, Soeren |4 auth | |
| 700 | 1 | |a Klautzer, Lisa |4 auth | |
| 700 | 1 | |a Mengistu, Tewodaj |4 auth | |
| 245 | 1 | 0 | |a Medicines as a Service |b A New Commercial Model for Big Pharma in the Postblockbuster World |
| 260 | |b RAND Corporation |c 2012 | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. | ||
| 540 | |a All rights reserved |4 http://oapen.org/content/about-rights | ||
| 546 | |a English | ||
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Health Sciences | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://www.jstor.org/stable/10.7249/OP381HLTH |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/115009 |7 0 |z DOAB: description of the publication |